What is it about?
In type II diabetes, sitagliptin should be used combined with metformin or pioglitazone to decrease the risk of pancreatitis.
Featured Image
Read the Original
This page is a summary of: Effect of metformin and pioglitazone on β-catenin and biochemical markers in sitagliptin-induced pancreatitis in diabetic rats, International Journal of Diabetes in Developing Countries, January 2015, Springer Science + Business Media,
DOI: 10.1007/s13410-014-0278-8.
You can read the full text:
Contributors
The following have contributed to this page
